Review articleRevealing quinquennial anticancer journey of Morpholine (cas 110-91-8): A SAR based review

Add time:08/21/2019    Source:sciencedirect.com

Morpholine, a six-membered heterocycle containing one nitrogen and one oxygen atom, is a moiety of great significance. It forms an important intermediate in many industrial and organic syntheses. Morpholine containing drugs are of high therapeutic value. Its wide array of pharmacological activity includes anti-diabetic, anti-emetic, growth stimulant, anti-depressant, bronchodilator and anticancer. Multi-drug resistance in cancer cases have emerged in the last few years and have led to the failure of many chemotherapeutic drugs. Newer treatment methods and drugs are being developed to overcome this problem. Target based drug discovery is an effective method to develop novel anticancer drugs. To develop newer drugs, previously reported work needs to be studied. Keeping this in mind, last five year's literature on morpholine used as anticancer agents has been reviewed and summarized in the paper herein.

We also recommend Trading Suppliers and Manufacturers of Morpholine (cas 110-91-8). Pls Click Website Link as below: cas 110-91-8 suppliers

Prev:Structural and thermal studies on some Morpholine (cas 110-91-8) complexes
Next:Discovery of Morpholine (cas 110-91-8)-based aryl sulfonamides as Nav1.7 inhibitors)